10 Results for "

monoclonal antibody immunomodulator

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "monoclonal antibody immunomodulator" in MCE Product Catalog:

Cat. No.: HY-P99295
CAS No.: 959963-46-3
Synonyms: RG 7160; RO 5083945; Anti-EGFR Recombinant antibody

Target:  

EGFR

Research Areas:  

Cancer

Imgatuzumab (RG 7160) is a humanized monoclonal antibody against the EGFR. Imgatuzumab acts as an immunomodulator. Imgatuzumab can be used in research of cancer .
loading...
    loading...
Cat. No.: HY-P99215
CAS No.: 1312797-14-0
Synonyms: Anti-EGFL7; RG 7414

Target:  

VEGFR

Research Areas:  

Cancer

Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition .
loading...
    loading...
Cat. No.: HY-P99952
CAS No.: 2249927-04-4
Synonyms: SCT400
Ripertamab (SCT400) is a recombinant human-mouse chimeric anti-CD20 IgG1κ monoclonal antibody. As an immunomodulator, ripertamab reduces the levels of pathogenic autoantibodies, alleviates immune complex deposition, and blocks the antigen-presenting function of cells. Ripertamab depletes CD20-positive cells. Ripertamab can induce infusion-related reactions, pulmonary toxicity, neutropenia and thrombocytopenia. Ripertamab is applicable to research related to non-Hodgkin's lymphoma, primary membranous nephropathy and idiopathic membranous nephropathy .
loading...
    loading...
Cat. No.: HY-P99606
CAS No.: 2473240-98-9
Synonyms: ZTS-00521426

Target:  

TGF-beta/Smad

Research Areas:  

Inflammation/Immunology

Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator .
loading...
    loading...
Cat. No.: HY-P99295A
Synonyms: RG 7160 (FUT8-KO); RO 5083945 (FUT8-KO); Anti-EGFR Recombinant antibody (FUT8-KO)

Target:  

EGFR

Research Areas:  

Cancer

Imgatuzumab (FUT8-KO) is a humanized monoclonal antibody against EGFR expressed in CHO cells with the fucosyltransferase 8 gene (FUT8) knocked out. Imgatuzumab is an immunomodulator. Imgatuzumab may be used in cancer research.
loading...
    loading...
Cat. No.: HY-P991729
CAS No.: 3037408-64-0
Synonyms: APG-777

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Zumilokibart (APG-777) is an anti-IL-13 IgG1κ type humanized antibody. The recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001). Zumilokibart can be used for the research of atopic dermatitis (AD) .
loading...
    loading...
Cat. No.: HY-P992105
CAS No.: 3062245-47-7

Target:  

ANGPTL

Research Areas:  

Inflammation/Immunology

Corveldebart is a monoclonal antibody of immunoglobulin G1-kappa that targets ANGPTL4. Corveldebart can be used as an immunomodulator .
loading...
    loading...
Cat. No.: HY-P992480

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

VAK-694 is a fully humanized anti-IL-4 monoclonal antibody. VAK-694 can be used for the research of seasonal allergic rhinitis .
loading...
    loading...
Cat. No.: HY-P992519
Synonyms: ADWA-11

Research Areas:  

Cancer

PF-06940434 (ADWA-11) is a monoclonal antibody targeting integrin αvβ8. PF-06940434 inhibits αvβ8-mediated TGF-β activation. PF-06940434 increases the accumulation of tumor-infiltrating CD8 + T cells and upregulates the expression of granzyme B and TNF-γ. PF-06940434 blocks the inhibitory effect of CD4 +CD25 + T cells on the cytotoxic activity of tumor CD8 + T cells. PF-06940434 enhances the anti-tumor efficacy of combination therapies with other immunomodulators or radiotherapy and induces long-term anti-tumor immunity. PF-06940434 can be used in the research of squamous cell carcinoma, breast cancer, colon cancer, and prostate adenocarcinoma .
loading...
    loading...
Cat. No.: HY-P992111
CAS No.: 3058391-18-4
Synonyms: UCB4594

Target:  

MHC

Research Areas:  

Cancer

Elfritatug (UCB4594) is a humanized monoclonal antibody targeting human leukocyte antigen-G (HLA-G). By binding to HLA-G on the surface of tumor cells, Elfritatug blocks its immunosuppressive effect, thereby enhancing the body's immune response against tumors .
loading...
    loading...